Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hermann Companies is a St. Louis-based family-owned private investment and management firm founded in 1956. The business operates as a family office and investment platform with exposure to private equity, venture capital, real estate, and private credit, and has also been described as a holding company and management consulting organization. Publicly available information indicates its core activities are investment-related rather than drug development, biotechnology, pharmaceuticals, or healthcare delivery. While Hermann has invested in a range of companies and sectors, it does not appear to be a life science operating company with an internal therapeutic pipeline. For biotech analysts, Hermann is best understood as a private investor with occasional exposure to health-, food-, or ag-adjacent portfolio companies rather than as a therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hermann Companies.